Two-thirds of patients in pivotal trials recruited from outside Europe
This article was originally published in Scrip
Executive Summary
Europe is recruiting a smaller share of patients involved in pivotal trials that form part of marketing authorization applications to the European Medicines Agency, according to the agency's own analysis. Between 2005 and 2011, the percentage of patients involved in such trials recruited in Europe fell from 37% to 31% with nearly two thirds of patients being recruited elsewhere.